Pharmaceutical intermediates
Ziprasidone Hydrochloride Intermediates
2 pharmaceutical intermediates for Ziprasidone Hydrochloride. Indication: Schizophrenia; Bipolar disorder and related disorders; Mania.
About Ziprasidone Hydrochloride
- Originator
- Pfizer Inc
- Indication
- Schizophrenia; Bipolar disorder and related disorders; Mania
- Approved Date
- 02/05/2001
Available intermediates
2 intermediates currently listed for Ziprasidone Hydrochloride. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 6-Chlorooxindole | 56341.37-8 | / | / |
| 6-Chloro-5-(2-chloroethyl)oxindole | 118289-55-7 | / | / |
Other programs under Z
Building toward Ziprasidone Hydrochloride?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →